Agent Capital
Finance · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1400 Main St Fl 1, Waltham, Massachusett...Phone Number
(617) 340-2538Website
www.agentcapital.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
1
1
1
About Agent Capital
Agent Capital is a healthcare venture capital firm that invests in novel therapeutics and treatments aimed at addressing unmet patient needs. The firm collaborates with scientists, entrepreneurs, and investors to foster the development of innovative healthcare solutions across various stages of development. Their investment focus includes key areas such as rare diseases, oncology, neurology, and immunology. Agent Capital is dedicated to guiding biotech companies towards significant milestones and successful exits.Explore more
Agent Capital Org Chart
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Agent Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Agent Capital has recently received funding, and reach out quickly before it becomes old news!
Click to see if Agent Capital had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Agent Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Agent Capital
Earning: See what the market has to say on Agent Capital recently announced quarterly report
Funding: Get notified immidiatlly once Agent Capital has new funding data
Product Launch: Get notified when Agent Capital launches new products
Check out if Agent Capital is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Agent Capital
Compare insights from companies similar to Agent Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5M
11-50
Private
-
1984
PF
Pascal FortinEntrepreneur-in-Residence. President and Chief Scientific Officer, Stealth NewCo
Company Profile Activity
Activity Insights
Agent Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Agent Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Agent Capital.
Agent Capital Tech Stack
A closer look at the technologies used by Agent Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Agent Capital News & Media
Cantai Therapeutics is Co-Founded by Agent Capital and 82VS to Advance Next-Generation Bispecific Antibodies for Autoimmune Diseases
WALTHAM, Mass.--(BUSINESS WIRE)--Cantai Therapeutics (“Cantai”) today announced its formation and the completion of a seed financing co-led by Agent Capital and 82VS (the affiliated venture studio of Alloy Therapeutics) with additional participation from Tellus BioVentures. The proceeds will be used to develop drug candidates to treat autoimmune and inflammatory disorders by developing cytokine-targeting bispecific antibodies that meaningfully improve the status quo for the millions of patientsStar Therapeutics Raises $90M in Series C Funding
Star Therapeutics, a South San Francisco, CA-based biotechnology company advancing antibody therapies, raised $90M in Series C funding. The round was led by Sofinnova Investments, and included new investors Qatar Investment Authority (QIA), Catalio Capital Management, Agent Capital, Soleus Capital, and NYBC Ventures, as well as participation from all existing investors including Westlake Village BioPartners, […] The post Star Therapeutics Raises $90M in Series C Funding appeared first on FinSMEsForesight Diagnostics Raises $58.75M in Series B Financing
Foresight Diagnostics, an Aurora, CO-based developer of cancer detection tests, raised $58.75M in Series B funding. The round was led by Foresite Capital, with participation by Civilization Ventures, Bluebird Ventures, Pear Ventures, Agent Capital, Stanford University, and The University of Colorado Healthcare Innovation Fund. As part of this funding, Uplaksh Kumar, Ph.D., will be joining the Foresight Diagnostics […] The post Foresight Diagnostics Raises $58.75M in Series B Financing appeared fFlare Therapeutics Raises $123M in Series B Financing
Flare Therapeutics, a Cambridge, MA-based biotechnology company targeting transcription factors, raised $123M in Series B funding. The round was led by GordonMD Global Investments LP and Pfizer Ventures, with participation from existing investors Boxer Capital, Casdin Capital, Eventide Asset Management, Invus Financial Advisors, Nextech Invest and Third Rock Ventures and new investors Agent Capital, Eli Lilly […] The post Flare Therapeutics Raises $123M in Series B Financing appeared first on Fi
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Agent Capital
Sign Up For FreeTo access detailed company insights
Agent Capital is a healthcare venture capital firm that invests in novel therapeutics and treatments aimed at addressing unmet patient needs. The firm collaborates with scientists, entrepreneurs, and investors to foster the development of innovative healthcare solutions across various stages of development. Their investment focus includes key areas... Read More
